Full datetime event:Thursday, March 21, 2019From 1:00 pm to 6:00 pm
479 Jessie Street
San Francisco, CA 94103
DescriptionNote: this is an invite-only event for investors.
Contact email@example.com for enquires.
PART I: Pre-seed & Seed (March 21st)
PART II: Series A & Beyond (June 18th)
Software investment is crowded. Deep Tech has higher starting costs, but benefits from strong walls and moats. Level up your knowledge of DT investment with experts, and improve your returns by learning to spot strong startups early.
BUILD YOUR INVESTMENT PLAYBOOK
Understand the milestones and metrics specific to early stage DT startups from prototype(s) to market, and how investors evaluate risks and opportunities.
WHO IS THIS FOR
VCs & CVCs
Corporate Development Executives
13:00 - 13:30 - Registration
13:30 - 14:15 - How Deep Tech Hardware Startups are Built
Building DT hardware today
Financing the early stages
Speaker: Cyril Ebersweiler (@hax_co), Founder & GP, HAX / SOSV
14:15 - 15:00 - Go-to-market and Early Growth
Key differences between consumer, industrial, medtech, etc.
Success metrics for pre-seed & seed teams
Speaker: Kate Whitcomb (@katewhitcomb), Partner, HAX
15:00 - 15:45 Break
15:45 - 17:00 - Playbooks Unveiled (pre-seed/seed VC panel)
Deep Tech investors share wins, losses, and their investment playbooks
Favorite sectors, Deal flow, Investment criteria, Post-mortems: the limits of prediction
Moderator: Benjamin Joffe (@benjaminjoffe), Partner, HAX
17:00 - 18:00 - Drinks and Networking
HAX is the world’s most active early stage investor in hardware, with offices in San Francisco and Shenzhen, the “Silicon Valley of Hardware” (Wired, Bloomberg).
HAX portfolio counts more than 270 startups in the robotics, health, enterprise and consumer space.
Co-investors include include Sequoia, Andreessen Horowitz and Founders Fund.
HAX is part of SOSV, a program-based VC fund with over US$500 million under management and global operations in hardware, life sciences, food, and Asia cross-border internet and mobile.
SOSV was ranked #3 most active early stage fund in 2018 by Crunchbase.